1 )Discuss the laboratory methods used to investigate haematological malignancies. Question 2 Discuss the steps built into the pre-transfusion process to avoid the administration of an incorrect blood component. What types of adverse reactions or adverse events may be seen, and which haemovigilan schemes are in place to monitor these? Investigating Haematological Malignancies and Pre-Transfusion Processes

Investigating Haematological Malignancies and Pre-Transfusion Processes

Investigating haematological malignancies is critical for providing precise diagnosis, treatment plans, and prognoses for patients. Laboratory methods used to investigate haematological malignancies include morphological assessment, cytochemistry, and immunophenotyping. Morphological assessment involves the microscopic examination of a patient’s blood or bone marrow sample to identify abnormal cells. Cytochemistry is used to detect enzymes in the cells, and immunophenotyping is used to determine the presence of antigens in the cells (Fenaux et al., 2017). All of these techniques are used to detect the presence and characteristics of haematological malignancies. The pre-transfusion process is designed to ensure that the correct blood component is administered to a patient. This process includes a series of steps to ensure accuracies, such as patient identification, antigen-antibody tests, and cross-matching (Transfusion, 2018). Adverse reactions or events that may occur from incorrect transfusions include allergic reactions, fever, and even organ failure (Fung et al., 2020). To ensure patient safety, hemovigilance. Cont…